×
Join our live online event
How top hedge funds use news to make money
form the stock market & how ordinary people are
copying their strategies
Register now!
form the stock market & how ordinary people are
copying their strategies
No thanks
IMRN – immuron limited - american depositary shares (US:NASDAQ)
DELAYED
$
| Volume Shares | |
| 1 Day Range | |
| Volume Ratio | |
| 52 Week High | |
| 52 Week Low |
| VWAP | |
| Today’s Volatility | |
| 20 Days Volatility | |
| Open | |
| Prior Close |
1D
5D
1M
3M
YTD
1Y
3Y
1 Day
IMRN
SPY
QQQ
Swipe to see more
Main News & Impact Reports
Date
Time
Symbol
Headline
Impact
3/5
06:24 am
imrn
Immuron and Calmino join up to treat Irritable Bowel Syndrome (IBS) [Yahoo! Finance]
Medium
Report
Immuron and Calmino join up to treat Irritable Bowel Syndrome (IBS) [Yahoo! Finance]
3/5
06:00 am
imrn
Immuron and Calmino join up to treat Irritable Bowel Syndrome (IBS)
Medium
Report
Immuron and Calmino join up to treat Irritable Bowel Syndrome (IBS)
1/17
07:41 am
imrn
Immuron Travelan® continued strong sales growth [Yahoo! Finance]
Low
Report
Immuron Travelan® continued strong sales growth [Yahoo! Finance]
1/17
06:00 am
imrn
Immuron Travelan® continued strong sales growth
High
Report
Immuron Travelan® continued strong sales growth
1/15
06:00 am
imrn
Immuron Announces New Research Collaboration targeting Antimicrobial Resistance
Medium
Report
Immuron Announces New Research Collaboration targeting Antimicrobial Resistance
1/14
07:38 am
imrn
Immuron Announces Travelan® Clinical Trial Update [Yahoo! Finance]
High
Report
Immuron Announces Travelan® Clinical Trial Update [Yahoo! Finance]
1/14
06:00 am
imrn
Immuron Announces Travelan® Clinical Trial Update
Low
Report
Immuron Announces Travelan® Clinical Trial Update
Date
Time
Symbol
Company Name
Action
%Chg
Date
Time
Action
From
To
Firm
Impact
%Chg
Date
Time
Symbol
Headline
Impact
3/7
06:14 am
imrn
Form 6-K Immuron Ltd For: Mar 07
Neutral
Report
Form 6-K Immuron Ltd For: Mar 07
3/5
08:31 am
imrn
Form 6-K Immuron Ltd For: Mar 05
Medium
Report
Form 6-K Immuron Ltd For: Mar 05
2/28
04:43 pm
imrn
Form 6-K Immuron Ltd For: Feb 28
Low
Report
Form 6-K Immuron Ltd For: Feb 28
2/19
06:01 am
imrn
Form 6-K Immuron Ltd For: Feb 19
Medium
Report
Form 6-K Immuron Ltd For: Feb 19
1/17
08:00 am
imrn
Form 6-K Immuron Ltd For: Jan 17
Medium
Report
Form 6-K Immuron Ltd For: Jan 17
1/15
08:00 am
imrn
Form 6-K Immuron Ltd For: Jan 15
High
Report
Form 6-K Immuron Ltd For: Jan 15
1/14
08:30 am
imrn
Form 6-K Immuron Ltd For: Jan 14
High
Report
Form 6-K Immuron Ltd For: Jan 14
1/10
07:26 am
imrn
Form 6-K Immuron Ltd For: Jan 10
Medium
Report
Form 6-K Immuron Ltd For: Jan 10
Stock Stats
| News Stats | |
|---|---|
| All News | |
| News Wires | |
| Media Monitoring | |
| SEC Edgar Filings | |
| Upgrades | |
| Downgrades | |
| Initiated | |
| Reiterated | |
| Last Earnings | |
| Last Earnings EPS | |
| Next Earnings | |
| Order Stats |
|---|
| Sub-Penny |
|
|
| Odd lot |
|
|
| Avg. bid-ask spread |
|
|
| Avg. bid-ask size |
|
|
| Shares at ask/bid |
|
|
| Off exchange |
|
|
Main News & Impact Reports
TOP News Gainers
4/20
Immuron North American Travelan® Sales Up 95%, Global Sales Up 60%
36.2%
6/12 US Department of Defense Reports Final Results from Travelan® Shigellosis Challenge Study 14.5%
10/2 Form 6-K Immuron Ltd For: Oct 02 13.1%
11/6 Form 6-K Immuron Ltd For: Nov 04 12.4%
9/4 Form 6-K Immuron Ltd For: Sep 04 9.6%
8/9 Form 6-K Immuron Ltd For: Aug 08 7.6%
3/25 Resignation of CEO & Director and cost cutting amidst COVID-19 7.3%
5/28 Form 424B5 Immuron Ltd 5.2%
10/4 Form 6-K Immuron Ltd For: Oct 04 4.6%
1/28 Form 6-K Immuron Ltd For: Jan 28 4.3%
6/12 US Department of Defense Reports Final Results from Travelan® Shigellosis Challenge Study 14.5%
10/2 Form 6-K Immuron Ltd For: Oct 02 13.1%
11/6 Form 6-K Immuron Ltd For: Nov 04 12.4%
9/4 Form 6-K Immuron Ltd For: Sep 04 9.6%
8/9 Form 6-K Immuron Ltd For: Aug 08 7.6%
3/25 Resignation of CEO & Director and cost cutting amidst COVID-19 7.3%
5/28 Form 424B5 Immuron Ltd 5.2%
10/4 Form 6-K Immuron Ltd For: Oct 04 4.6%
1/28 Form 6-K Immuron Ltd For: Jan 28 4.3%
TOP News Decliners
6/12
Immuron up 11% on encouraging Travelan data [Seeking Alpha]
-41.3%
5/23 Form 424B5 Immuron Ltd -27.2%
10/2 New U.S. Department of Defense Research Collaboration with Immuron to Develop and Clinically evaluate a New Therapeutic against Campylobacter -16.5%
7/19 Form 6-K Immuron Ltd For: Jul 19 -15.3%
7/16 Immuron Announces Proposed Public Offering of ADSs -11.6%
8/8 Immuron Reports Results in Severe Alcoholic Hepatitis Clinical Trial -10.1%
9/30 IMMURON LTD/S (NASDAQ: IMRN) was downgraded by analysts at ValuEngine from a "buy" rating to a "hold" rating. -10.1%
3/3 Immuron Provides Update on First Half of FY20 Results -7.5%
11/21 Immuron Plans Phase 3 trial for IMM-124E to Prevent Travelers’ Diarrhea -5.6%
7/23 Form 6-K Immuron Ltd For: Jul 23 -4.9%
5/23 Form 424B5 Immuron Ltd -27.2%
10/2 New U.S. Department of Defense Research Collaboration with Immuron to Develop and Clinically evaluate a New Therapeutic against Campylobacter -16.5%
7/19 Form 6-K Immuron Ltd For: Jul 19 -15.3%
7/16 Immuron Announces Proposed Public Offering of ADSs -11.6%
8/8 Immuron Reports Results in Severe Alcoholic Hepatitis Clinical Trial -10.1%
9/30 IMMURON LTD/S (NASDAQ: IMRN) was downgraded by analysts at ValuEngine from a "buy" rating to a "hold" rating. -10.1%
3/3 Immuron Provides Update on First Half of FY20 Results -7.5%
11/21 Immuron Plans Phase 3 trial for IMM-124E to Prevent Travelers’ Diarrhea -5.6%
7/23 Form 6-K Immuron Ltd For: Jul 23 -4.9%
Don’t Miss Out On The Next BIG Stock Move
Never get left behind with our daily ‘Shakers & Movers’ newsletter. Discover the biggest gainer or loser in the stock market, and learn exactly WHY it moved. To find out which one caught Wall Street by surprise TODAY, sign up to our newsletter below: